Wall Street Access Asset Management, LLC Takeda Pharmaceutical CO LTD Transaction History

Wall Street Access Asset Management, LLC

$261 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Apr 25, 2024	SELL	$13.36 - $15.43 $7,054 - $8,147	-528 Reduced 2.24%	23,063 $329,000
Q4 2023 Feb 13, 2024	SELL	$13.36 - $15.43 $7,054 - $8,147	-528 Reduced 2.24%	23,063 $329,000
Q3 2023 Apr 25, 2024	SELL	$15.03 - $16.32 $736 - $799	-49 Reduced 0.21%	23,591 $364,000
Q3 2023 Nov 06, 2023	SELL	$15.03 - $16.32 $736 - $799	-49 Reduced 0.21%	23,591 $364,000
Q2 2023 Apr 25, 2024	SELL	$15.57 - $17.11 $15 - $17	-1 Reduced -0.0%	23,640 $371,000
Q2 2023 Aug 10, 2023	SELL	$15.57 - $17.11 $15 - $17	-1 Reduced -0.0%	23,640 $371,000
Q1 2023 Apr 25, 2024	BUY	$15.28 - $16.48 $687 - $741	45 Added 0.19%	23,641 $389,000
Q1 2023 May 11, 2023	BUY	$15.28 - $16.48 $687 - $741	45 Added 0.19%	23,641 $389,000
Q4 2022 Apr 25, 2024	BUY	$12.42 - $15.62 $6,619 - $8,325	533 Added 2.31%	23,596 $368,000
Q4 2022 Feb 02, 2023	BUY	$12.42 - $15.62 $3,837 - $4,826	309 Added 1.33%	23,596 $368,000
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $5,606 - $12,548	438 Added 1.92%	23,287 $302,000
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $2,755 - $3,156	210 Added 0.93%	22,849 $320,000
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $47,809 - $54,200	-3,531 Reduced 13.49%	22,639 $324,000
Q4 2021 Feb 15, 2022	SELL	$13.17 - $16.4 $128,802 - $160,392	-9,780 Reduced 27.2%	26,170 $356,000
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $272,063 - $288,086	16,691 Added 86.67%	35,950 $588,000
Q1 2021 May 13, 2021	BUY	$16.71 - $19.9 $95,163 - $113,330	5,695 Added 41.99%	19,259 $351,000
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $76 - $94	-5 Reduced 0.04%	13,564 $246,000
Q3 2020 Nov 13, 2020	SELL	$17.1 - $19.19 $32,165 - $36,096	-1,881 Reduced 12.17%	13,569 $242,000
Q2 2020 Nov 02, 2021	SELL	$14.59 - $19.5 $3,662 - $4,894	-251 Reduced 1.6%	15,450 $277,000
Q1 2020 May 14, 2020	SELL	$13.02 - $20.31 $14,061 - $21,934	-1,080 Reduced 6.44%	15,701 $238,000
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $3,443 - $4,249	-204 Reduced 1.2%	16,781 $330,000
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $15,358 - $17,108	-951 Reduced 5.3%	16,985 $292,000
Q2 2019 Aug 13, 2019	BUY	$16.58 - $20.49 $297,378 - $367,508	17,936 New	17,936 $317,000

Others Institutions Holding TAK

# of Institutions

337

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

Capital Research Global Investors Los Angeles, CA

13.1M
Shares

$178 Million
0.04% of portfolio
Morgan Stanley New York, NY

5.35M
Shares

$72.6 Million
0.01% of portfolio
Mondrian Investment Partners LTD London, X0

5.09M
Shares

$69.1 Million
1.21% of portfolio
Arrowstreet Capital, Limited Partnership Boston, MA

4.64M
Shares

$62.9 Million
0.05% of portfolio
Goldman Sachs Group Inc New York, NY

4.56M
Shares

$61.8 Million
0.01% of portfolio

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wall Street Access Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wall Street Access Asset Management, LLC with notifications on news.

Account